Cargando…
Programmed Hydrolysis in Designing Paclitaxel Prodrug for Nanocarrier Assembly
Nanocarriers delivering prodrugs are a way of improving in vivo effectiveness and efficiency. For therapeutic efficacy, the prodrug must hydrolyze to its parent drug after administration. Based on the fact that the hydrolysis is impeded by steric hindrance and improved by sufficient polarity, in thi...
Autores principales: | Fu, Q., Wang, Y., Ma, Y., Zhang, D., Fallon, J. K., Yang, X., Liu, D., He, Z., Liu, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499798/ https://www.ncbi.nlm.nih.gov/pubmed/26166066 http://dx.doi.org/10.1038/srep12023 |
Ejemplares similares
-
Hypoxia-activated prodrugs and redox-responsive nanocarriers
por: Zeng, Yun, et al.
Publicado: (2018) -
Prodrug Strategies for Paclitaxel
por: Meng, Ziyuan, et al.
Publicado: (2016) -
Probing the fluorination effect on the self-assembly characteristics, in vivo fate and antitumor efficacy of paclitaxel prodrug nanoassemblies
por: Wang, Xin, et al.
Publicado: (2021) -
Self-Assembled Disulfide Bond Bearing Paclitaxel—Camptothecin Prodrug Nanoparticle for Lung Cancer Therapy
por: Gao, Jingyan, et al.
Publicado: (2020) -
Self-Assembly of pH-Labile Polymer Nanoparticles for Paclitaxel Prodrug Delivery: Formulation, Characterization, and Evaluation
por: Levit, Shani L., et al.
Publicado: (2020)